Home World News Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic... World News Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic Hodgkin’s Lymphoma By Ogkologos - October 30, 2024 3251 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the S1826 study Source RELATED ARTICLESMORE FROM AUTHOR New on NCI’s Websites for November 2024 A Short-Course of Induction Chemotherapy Followed by Chemoradiotherapy Significantly Improves Survival in Patients with Locally Advanced Cervical Cancer Targeted Therapy, Driven by Comprehensive Genomic Profiling and Molecular Tumour Board, Improves Outcomes In Pretreated Patients with Metastatic Cancer MOST POPULAR Higher Risk of Heart Failure Seen in Some Cancers March 26, 2018 The Frontline Oncology Workforce Unites to Reduce the Burden of Cancer... September 9, 2022 A Message from the ESMO President March 17, 2020 Seeing a Promising Future for Progress against Childhood Cancer September 16, 2021 Load more HOT NEWS FDA Approves Niraparib and Abiraterone Acetate Plus Prednisone for BRCA-mutated Metastatic... Outcomes of Cancer Patients with SARS-CoV-2 Infection in Veneto FDA Approves Belumosudil to Treat Chronic Graft-Versus-Host Disease Texas Baby Is Born With Almost No Skin On His Body,...
